David Ozog

4.9k total citations
97 papers, 2.6k citations indexed

About

David Ozog is a scholar working on Dermatology, Surgery and Epidemiology. According to data from OpenAlex, David Ozog has authored 97 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Dermatology, 22 papers in Surgery and 16 papers in Epidemiology. Recurrent topics in David Ozog's work include Dermatologic Treatments and Research (36 papers), Laser Applications in Dentistry and Medicine (13 papers) and Facial Rejuvenation and Surgery Techniques (11 papers). David Ozog is often cited by papers focused on Dermatologic Treatments and Research (36 papers), Laser Applications in Dentistry and Medicine (13 papers) and Facial Rejuvenation and Surgery Techniques (11 papers). David Ozog collaborates with scholars based in United States, United Kingdom and Philippines. David Ozog's co-authors include Ali M. Rkein, Iltefat Hamzavi, Ronald L. Moy, Henry W. Lim, Bassel H. Mahmoud, Emily P. Tierney, Austin Liu, Indermeet Kohli, Qing‐Sheng Mi and Jill Waibel and has published in prestigious journals such as The Journal of Immunology, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

David Ozog

89 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Ozog United States 29 1.6k 556 485 394 352 97 2.6k
William A. Farinelli United States 31 1.9k 1.2× 752 1.4× 287 0.6× 624 1.6× 338 1.0× 71 3.1k
Christopher B. Zachary United States 33 2.1k 1.4× 715 1.3× 155 0.3× 535 1.4× 473 1.3× 131 3.5k
Eric F. Bernstein United States 34 2.4k 1.5× 681 1.2× 193 0.4× 616 1.6× 243 0.7× 111 3.5k
Dong Won Lee South Korea 32 532 0.3× 1.4k 2.5× 322 0.7× 827 2.1× 255 0.7× 280 3.9k
H. A. Martino Neumann Netherlands 29 1.1k 0.7× 912 1.6× 291 0.6× 92 0.2× 902 2.6× 91 2.8k
Uwe Hillen Germany 34 1.2k 0.8× 269 0.5× 308 0.6× 317 0.8× 381 1.1× 136 3.8k
E. Victor Ross United States 32 2.5k 1.6× 492 0.9× 219 0.5× 938 2.4× 329 0.9× 112 3.1k
Brian D. Zelickson United States 33 2.1k 1.4× 902 1.6× 74 0.2× 476 1.2× 379 1.1× 94 3.5k
Jürg Hafner Switzerland 34 863 0.6× 1.0k 1.8× 350 0.7× 69 0.2× 943 2.7× 160 3.2k
Taro Kono Japan 28 1.7k 1.1× 796 1.4× 116 0.2× 389 1.0× 160 0.5× 109 2.5k

Countries citing papers authored by David Ozog

Since Specialization
Citations

This map shows the geographic impact of David Ozog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ozog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ozog more than expected).

Fields of papers citing papers by David Ozog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ozog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ozog. The network helps show where David Ozog may publish in the future.

Co-authorship network of co-authors of David Ozog

This figure shows the co-authorship network connecting the top 25 collaborators of David Ozog. A scholar is included among the top collaborators of David Ozog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ozog. David Ozog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veenstra, Jesse, David Ozog, & Sunita Ghosh. (2025). Response to Yang et al’s “A Disproportionality Analysis on Benzoyl Peroxide and Its Risk of Malignancy Using the FDA Adverse Event Reporting System”. Journal of Investigative Dermatology. 145(12). 3199–3201.
2.
Ozog, David, et al.. (2024). Using Neuromodulators to Improve Scar Formation, Keloids, Rosacea, and Antiaging. Dermatologic Surgery. 50(9S). S91–S96.
3.
Maghfour, Jalal, et al.. (2024). Photobiomodulation CME part I: Overview and mechanism of action. Journal of the American Academy of Dermatology. 91(5). 793–802. 25 indexed citations
4.
Young, Albert T., et al.. (2023). Patients and dermatologists are largely satisfied with ChatGPT-generated after-visit summaries: A pilot study. JAAD International. 15. 33–35. 1 indexed citations
5.
Hamzavi, Iltefat, Congcong Yin, Jugmohit Toor, et al.. (2023). Disease associated monocytes contribute to the inflammatory milieu in hidradenitis suppurativa and have dysregulated expression of transposable elements. The Journal of Immunology. 210(Supplement_1). 72.10–72.10. 2 indexed citations
6.
Veenstra, Jesse, David Ozog, Indra Adrianto, et al.. (2023). Distinguishing Keratoacanthoma from Well-Differentiated Cutaneous Squamous Cell Carcinoma Using Single-Cell Spatial Pathology. Journal of Investigative Dermatology. 143(12). 2397–2407.e8. 4 indexed citations
7.
Ozog, David, et al.. (2023). Retrospective study of keloid formation after CO2 excision therapy for hidradenitis suppurativa. Journal of the American Academy of Dermatology. 89(1). 181–182. 4 indexed citations
8.
Lyons, Alexis B., David Ozog, Henry W. Lim, et al.. (2022). The Detroit Keloid Scale: A Validated Tool for Rating Keloids. Facial Plastic Surgery & Aesthetic Medicine. 25(2). 119–125. 4 indexed citations
9.
Zhou, Li, Aimin Jiang, Jesse Veenstra, David Ozog, & Qing‐Sheng Mi. (2022). The Roles of Skin Langerhans Cells in Immune Tolerance and Cancer Immunity. Vaccines. 10(9). 1380–1380. 18 indexed citations
10.
Narla, Shanthi, et al.. (2021). Cosmetic Practices in the COVID-19 Era. PubMed Central. 4(1). 109–121. 1 indexed citations
11.
Veenstra, Jesse, Peter Dimitrion, Yi Yao, et al.. (2021). Research Techniques Made Simple: Use of Imaging Mass Cytometry for Dermatological Research and Clinical Applications. Journal of Investigative Dermatology. 141(4). 705–712.e1. 18 indexed citations
12.
Dimitrion, Peter, Li Zhou, David Ozog, et al.. (2021). Insights from γ-Secretase: Functional Genetics of Hidradenitis Suppurativa. Journal of Investigative Dermatology. 141(8). 1888–1896. 17 indexed citations
13.
Friedman, Ben J., et al.. (2021). A clinical and biological review of keratoacanthoma*. British Journal of Dermatology. 185(3). 487–498. 27 indexed citations
14.
Kohli, Indermeet, Alexis B. Lyons, Shanthi Narla, et al.. (2020). UVC Germicidal Units: Determination of Dose Received and Parameters to be Considered for N95 Respirator Decontamination and Reuse. Photochemistry and Photobiology. 96(5). 1083–1087. 12 indexed citations
15.
Torres, Angeli Eloise, Shanthi Narla, Alexis B. Lyons, et al.. (2020). Spectrum of virucidal activity from ultraviolet to infrared radiation. Photochemical & Photobiological Sciences. 19(10). 1262–1270. 28 indexed citations
16.
Ozog, David, Ali M. Rkein, Sabrina G. Fabi, et al.. (2016). Photodynamic Therapy: A Clinical Consensus Guide. Dermatologic Surgery. 42(7). 804–827. 193 indexed citations
17.
Connolly, Karen, John G. Albertini, Christopher J. Miller, & David Ozog. (2015). The Suspension (Frost) Suture. Dermatologic Surgery. 41(3). 406–410. 16 indexed citations
18.
Qu, Le, Austin Liu, Li Zhou, et al.. (2012). Clinical and molecular effects on mature burn scars after treatment with a fractional CO2 laser. Lasers in Surgery and Medicine. 44(7). 517–524. 114 indexed citations
19.
Ozog, David, et al.. (2006). Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy.. PubMed. 5(6). 556–61. 19 indexed citations
20.
Pachman, Lauren M., Patricia A. Lynch, Richard K. Silver, David Ozog, & Andrew K. Poznanski. (1989). Primary immunodeficiency in children: An update. Current Problems in Pediatrics. 19(1). 7–64. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026